Neuberger Berman Group
INSP icon

Neuberger Berman Group’s Inspire Medical Systems INSP Stock Holding History

Neuberger Berman Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
+8,423
New +$399K ﹤0.01% 1920
2025
Q3 		– Sell
-99,791
Closed -$12.9M – 2094
2025
Q2 		$12.9M Sell
99,791
-363
-0.4% -$52.6K 0.01% 739
2025
Q1 		$16M Buy
100,154
+15,929
+19% +$2.88M 0.01% 679
2024
Q4 		$15.6M Buy
84,225
+4,140
+5% +$804K 0.01% 715
2024
Q3 		$16.9M Sell
80,085
-1,398
-2% -$243K 0.01% 692
2024
Q2 		$10.9M Buy
81,483
+18,907
+30% +$3.58M 0.01% 764
2024
Q1 		$13.4M Sell
62,576
-39,138
-38% -$7.67M 0.01% 743
2023
Q4 		$20.7M Buy
101,714
+53,985
+113% +$8.75M 0.01% 765
2023
Q3 		$9.47M Buy
47,729
+566
+1% +$143K 0.01% 758
2023
Q2 		$15.3M Buy
47,163
+26,793
+132% +$7.66M 0.01% 666
2023
Q1 		$4.77M Buy
20,370
+1,139
+6% +$288K ﹤0.01% 889
2022
Q4 		$4.84M Buy
19,231
+6,032
+46% +$1.29M ﹤0.01% 870
2022
Q3 		$2.34M Sell
13,199
-38
-0.3% -$7.64K ﹤0.01% 1041
2022
Q2 		$2.42M Buy
13,237
+463
+4% +$92.3K ﹤0.01% 1069
2022
Q1 		$3.28M Buy
12,774
+465
+4% +$106K ﹤0.01% 1065
2021
Q4 		$2.75M Buy
12,309
+1,866
+18% +$456K ﹤0.01% 1112
2021
Q3 		$2.35M Sell
10,443
-7,529
-42% -$1.57M ﹤0.01% 1126
2021
Q2 		$3.47M Buy
17,972
+2,124
+13% +$421K ﹤0.01% 1050
2021
Q1 		$3.28M Sell
15,848
-5,242
-25% -$1.11M ﹤0.01% 1050
2020
Q4 		$3.97M Sell
21,090
-4,510
-18% -$737K ﹤0.01% 967
2020
Q3 		$3.3M Sell
25,600
-104,729
-80% -$11.5M ﹤0.01% 953
2020
Q2 		$11.3M Buy
130,329
+97,279
+294% +$7.48M 0.01% 692
2020
Q1 		$1.99M Sell
33,050
-6,950
-17% -$514K ﹤0.01% 946
2019
Q4 		$2.97M Hold
40,000
– – ﹤0.01% 947
2019
Q3 		$2.44M Buy
40,000
+800
+2% +$52.7K ﹤0.01% 972
2019
Q2 		$2.38M Buy
39,200
+15,200
+63% +$819K ﹤0.01% 987
2019
Q1 		$1.36M Buy
24,000
+7,500
+45% +$405K ﹤0.01% 1050
2018
Q4 		$697K Buy
+16,500
New +$702K ﹤0.01% 1186
2018
Q3 		– Sell
-15,900
Closed -$567K – 1658
2018
Q2 		$567K Buy
+15,900
New +$513K ﹤0.01% 1369

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group's INSP Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 8,423 shares worth $376K. The stake represents ﹤0.01% of the portfolio and ranks #1920 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in INSP as recently as Q2 2025.

Neuberger Berman Group first reported a position in INSP in Q2 2018 and has held it in 29 quarters since. The position peaked at $20.7M in Q4 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Neuberger Berman Group held 8,423 shares of Inspire Medical Systems worth $376K as of Q2 2026.
  • Inspire Medical Systems was a new Neuberger Berman Group position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1920 holding.
  • Neuberger Berman Group first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 29 quarters since.
  • Neuberger Berman Group's Inspire Medical Systems position peaked at $20.7M in Q4 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.